Hawthorn Berry 1500 mg

Hawthorn Berry 1500 mg

Nature's Answer4.7 (57 ratings)
Format:Capsule Quantity: 90 Capsule(s) · 30 servings
Goals
$9.74 $0.32 per serving

About this product

Three capsules deliver 1,500 mg of Crataegus monogyna hawthorn berry. The species, plant part, and substantial whole-herb amount are all clearly identified.

No flavonoid or procyanidin standardization is given, so active potency may vary. Berry powder also has less direct alignment with the characterized leaf-and-flower extracts emphasized in parts of the supplied evidence.

The low serving cost supports economical focused use, though three capsules and only thirty servings reduce convenience. It fits users who prefer a high whole-berry amount over a concentrated extract.

Who is it for
  • Adults seeking high-dose hawthorn berry
  • Users who prefer whole herb to extract
  • People comfortable taking three capsules
Best for
  • High-dose berry powder
  • Species-traceable hawthorn use
  • Economical focused supplementation

Pros

  • Provides 1,500 mg hawthorn berry
  • Names Crataegus monogyna
  • Clearly identifies the plant part
  • Simple single-herb formula

Cons

  • Requires three capsules
  • No active-marker standardization
  • Only 30 servings
  • Berry-only formula covers one narrow pathway

Warnings

  • Hawthorn may intensify antihypertensive medicines or nitrates and lower blood pressure too far.
  • Use with digoxin or other cardiac medicines requires prescriber approval.
  • Stop use and seek guidance if dizziness, faintness, or unusual heart symptoms occur.

Product analysis

82 out of 100
A high, species-identified berry dose offers clear whole-herb value, but absent standardization and a three-capsule serving limit precision and convenience.

AI assessment of the formula, label and price. How scoring works

Nutrient quality84

Crataegus monogyna berry is specifically identified, though the powder lacks active standardization. The high whole-herb amount provides substantial depth, and the single botanical offers focused cardiovascular support.

.
Ingredient transparency86

Every listed active has a specific amount and no proprietary blend obscures the formula. Complete intake directions and inactive ingredients are not supplied, leaving part of the label unverified.

.
Customer satisfaction63

The supplied aggregate satisfaction level is strong. The limited feedback volume leaves meaningful uncertainty.

.
Value for money90

The substantial amount and clear species support the modest cost. The serving provides good value for a high whole-herb dose, and the product compares favorably among non-extract hawthorn options.

.
Format
Capsule
Container
90 Capsule(s)
Per serving
$0.32
Customer rating
4.7 · 57 ratings
Report analysis

Goals

Cardiovascular Support
Impact
Highest effect
A+ Ingredient FitC- PathwaysB+ EvidenceA+ Formulation Logic
Hawthorn · 1500 mg

Hawthorn Berry 1500 mg declares 1,500 mg per serving and names Crataegus monogyna, but does not identify a standardized trial preparation. The ingredient is tied to vascular tone and sodium balance, its only covered pathway. The serving amount exceeds the largest supplied dose reference, which does not establish greater benefit or suitability at that exposure.

How this product is rated for Cardiovascular Support

Ingredient fit97

Hawthorn is the only goal-linked ingredient, with no off-goal actives; links to another goal slightly reduce focus.
Goal fit
Hawthorn is focused on this goal, with no off-goal actives, though it is linked to another goal.
Dose adequacy
The 1,500 mg serving exceeds the highest amount considered in the supplied dose references.

Pathways55

Hawthorn relates to vascular tone and sodium balance, but not the other target pathways.
Depth
Vascular tone and sodium balance is the only covered pathway.
Breadth
It covers one target pathway: vascular tone and sodium balance.

Evidence81

Hawthorn has goal-related evidence in the supplied references, but the label does not establish a match to the standardized extract used in trials.
Evidence strength
Hawthorn has relevant supplied evidence, but its trial preparation is not identified on the label.
Studied preparation
A hawthorn preparation is represented in studies, but the product's exact extract is not confirmed.

Formulation logic100

Hawthorn needs no partner here, and no listed conflict is present.
Partner coverage
Hawthorn works alone under the supplied ingredient profile.
Conflicts
No listed conflict is present in the supplied facts.
Effective doses
The amount is above the supplied references; more does not establish greater benefit or safety.
Study evidence
Hawthorn Supportive 28 studies
Heart Health
Impact
High effect
A+ Ingredient FitD- PathwaysC+ EvidenceA+ Formulation Logic
Study evidence
Hawthorn Supportive 27 studies

Ingredients

IngredientAmount per servingScore
Hawthorn (Crataegus monogyna)
1500 mg 71
Gluten Free Adults 18–50 Vegan Kosher Dairy Free Vegetarian
Report overview
C- Composition And Label DisclosureA+ Commercial Price And Usability
Hawthorn 1500 mg lists 1,500 mg of Crataegus monogyna and names the hawthorn species. It gives no marker percentage or extract ratio, while the serving cost is low.
How this ingredient is rated

Composition and Label Disclosure57

Crataegus monogyna is named, but no marker percentage or preparation ratio is given.
Marker and Preparation Disclosure
The label gives no marker percentage or extract ratio for the hawthorn.
Species Name Disclosure
The label identifies Crataegus monogyna, a specific hawthorn species.

Composition and Label Disclosure

The label lists 1,500 mg of Crataegus monogyna per serving.

Commercial Price and Usability100

The serving price is low.
Commercial Price per Labeled Serving
The serving cost is in a low range.
Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Hawthorn (Crataegus spp.) Clinically Significantly Reduces Blood Pressure in Hypertension: A Meta-Analysis of Randomized Placebo-Controlled Clinical Trials.
    Szikora Z; Mátyus RO; Szabó BV; Csupor D; Tóth B · Pharmaceuticals (Basel, Switzerland) · 2025
    Meta-analysis428 participants6 studies pooledHeart Health Cardiovascular Support forHawthorn
  2. Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials.
    Pittler MH; Schmidt K; Ernst E · The American journal of medicine · 2003
    Meta-analysis632 participants13 studies pooledHeart Health forHawthorn
  3. Hawthorn Extract Randomized Blinded Chronic Heart Failure (HERB CHF) trial.
    Zick SM; Vautaw BM; Gillespie B; Aaronson KD · European journal of heart failure · 2010
    Randomized trial120 participantsHeart Health forHawthorn
  4. Effects of Hawthorn Fruit Extract Drink in Chinese Patients With Mild Hypertension and/or Hyperlipidaemia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
    Zeng W; Chu TTW; Fok BSP; Ho WKK; Chan JCN; Tomlinson B · Dose-response : a publication of International Hormesis Society · 2024
    Randomized trial61 participantsCardiovascular Support forHawthorn
  5. Hawthorn Herb Increases the Risk of Bleeding after Cardiac Surgery: An Evidence-Based Approach.
    Rababa'h AM; Altarabsheh SE; Haddad O; Deo SV; Obeidat Y; Al-Azzam S · The heart surgery forum · 2017
    Observational study116 participantsCardiovascular Support forHawthorn
  6. Real world effectiveness of Hawthorn special extract WS 1442 in a retrospective cohort study from Germany.
    Wyss C; Gündling PW; Kostev K · Scientific reports · 2024
    Cohort study9,100 participantsCardiovascular Support forHawthorn
  7. A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II.
    Degenring FH; Suter A; Weber M; Saller R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2003
    Randomized trial143 participantsCardiovascular Support forHawthorn
  8. [Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)].
    Weikl A; Assmus KD; Neukum-Schmidt A; Schmitz J; Zapfe G; Noh HS; Siegrist J · Fortschritte der Medizin · 1996
    Randomized trial136 participantsCardiovascular Support forHawthorn
  9. Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442.
    Habs M · Forschende Komplementarmedizin und klassische Naturheilkunde = Research in complementary and natural classical medicine · 2005
    Cohort study952 participantsCardiovascular Support forHawthorn
  10. [Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure].
    Rietbrock N; Hamel M; Hempel B; Mitrovic V; Schmidt T; Wolf GK · Arzneimittel-Forschung · 2001
    Randomized trial88 participantsHeart Health forHawthorn
  11. Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II.
    Zapfe jun G · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2002
    Randomized trial40 participantsHeart Health forHawthorn
  12. Baseline severity but not gender modulates quantified Crataegus extract effects in early heart failure--a pooled analysis of clinical trials.
    Eggeling T; Regitz-Zagrosek V; Zimmermann A; Burkart M · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Meta-analysis687 participants10 studies pooledHeart Health forHawthorn